PRELI is a mitochondrial regulator of human primary T-helper cell apoptosis, STAT6, and Th2-cell 



differentiation by Tahvanainen, Johanna et al.
doi:10.1182/blood-2008-07-166553
Prepublished online October 22, 2008;
2009 113: 1268-1277
 
 
 
 
Westermarck, Kanury V. S. Rao and Riitta Lahesmaa
Johanna Tahvanainen, Teemu Kallonen, Hanna Lähteenmäki, Kaisa M. Heiskanen, Jukka
 
apoptosis, STAT6, and Th2-cell differentiation
PRELI is a mitochondrial regulator of human primary T-helper cell
 http://bloodjournal.hematologylibrary.org/content/113/6/1268.full.html
Updated information and services can be found at:
 http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests
Information about reproducing this article in parts or in its entirety may be found online at:
 http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints
Information about ordering reprints may be found online at:
 http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml
Information about subscriptions and ASH membership may be found online at:
 Copyright 2011 by The American Society of Hematology; all rights reserved.
Washington DC 20036.
by the American Society of Hematology, 2021 L St, NW, Suite 900, 
Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly
 
 
 
 
 For personal use only. by guest on May 27, 2011. bloodjournal.hematologylibrary.orgFrom 
IMMUNOBIOLOGY
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The identification of novel factors regulat-
ing human T helper (Th)–cell differentia-
tion into functionally distinct Th1 and Th2
subsets is important for understanding
the mechanisms behind human autoim-
mune and allergic diseases. We have
identified a protein of relevant evolution-
ary and lymphoid interest (PRELI), a novel
protein that induces oxidative stress and
a mitochondrial apoptosis pathway in hu-
man primary Th cells. We also demon-
strated that PRELI inhibits Th2-cell devel-
opment and down-regulates signal
transducer and activator of transcription
6 (STAT6), a key transcription factor driv-
ing Th2 differentiation. Our data suggest
that calpain, an oxidative stress–induced
cysteine protease, is involved in the
PRELI-induced down-regulation of STAT6.
Moreover, we observed that a strong T-
cell receptor (TCR) stimulus induces ex-
pression of PRELI and inhibits Th2 devel-
opment. Our results suggest that PRELI
is involved in a mechanism wherein the
strength of the TCR stimulus influences
the polarization of Th cells. This study
identifies PRELI as a novel factor influenc-
ing the human primary Th-cell death and
differentiation. (Blood. 2009;113:
1268-1277)
Introduction
Differentiation of human CD4 T helper (Th) cells into function-
ally distinct Th1 and Th2 subsets plays a central role in the
pathogenesis of human allergic and inflammatory diseases. The
most potent stimuli influencing this process are the cytokines
interleukin (IL)–12 and IL-4.1,2 Signal transducer and activator of
transcription 6 (STAT6) is an important transducer of the IL-4–
induced signaling pathway leading to Th2 differentiation.3
The strength of the T-cell receptor (TCR) signal also influences
the direction of the Th1/Th2 polarization. A strong TCR stimulus
tends to enhance Th1 differentiation, whereas weak TCR signals
favor Th2 polarization.4,5 Th1 and Th2 cells also differ in terms of
their susceptibility to apoptosis, with Th2 cells being more resistant
to apoptotic cell death than Th1 cells.6 IL-4 prevents apoptosis in
several cell types, but the molecular mechanisms involved are
largely unknown. In T cells, STAT6 does not seem to be required
for the antiapoptotic effect of IL-4,7 indicating that the IL-4–
induced Th2 differentiation and protection from apoptosis repre-
sent distinct signaling cascades emanating from the same receptor.
In an earlier study by our group, IL-4 was shown to inhibit
caspase-3 activity during the early phases of human Th2 differentia-
tion while up-regulating the expression of the antiapoptotic pro-
teins BCL-2 and BCL-XL.8 Other studies have also demonstrated
that the IL-4 signaling pathway regulates apoptosis through
regulation of mitochondrial proteins,9 and by maintaining the
mitochondrial membrane potential (m).10
The activity of STAT6 is tightly regulated through several
mechanisms (for a review, see Hebenstreit et al11), including
tyrosine and serine phosphorylation and methylation. Inhibition of
STAT6 signaling is controlled directly by specific phosphatases, as
well as indirectly by suppressor of cytokine signaling (SOCS)
proteins. In addition, several studies indicate that STAT6 is
negatively regulated by proteolytic degradation. In mouse mast
cells, STAT6 is proteolytically cleaved by both a protease belong-
ing to the elastase family and by activated calpain. This cleavage
generates truncated products of 65 and 70 kDa, which then
function as dominant negative forms of STAT6.12 In mouse T-cell
lines, activated STAT6 is completely degraded by calpain.13 The
physiologic role of calpain-mediated cleavage of STAT6 is cur-
rently unclear. Calpains are calcium-dependent proteases impli-
cated in cell proliferation, apoptosis, and differentiation.14
In this study we identify PRELI (protein of relevant evolution-
ary and lymphoid interest) as a novel activation-induced gene in
human primary Th cells. PRELI has previously been reported to be
highly expressed in adult lymph nodes and peripheral blood
leukocytes. In addition, based on its high expression levels in fetal
liver and germinal center B lymphocytes, PRELI has been pro-
posed to be important for B-cell development.15 To date, the
cellular role of PRELI has been obscure. It is an evolutionarily
conserved protein that is, in mice, coexpressed with Rab24, a
member of the Rab GTPase family,16 which is thought to be
involved in autophagy-related processes.17 We report for the first
time that PRELI is also highly induced in human primary CD4
Th cells in response to TCR activation. Functionally, this study
characterizes PRELI as a novel regulator of the mitochondria-
mediated apoptosis pathway in human primary Th cells. In addi-
tion, we demonstrate that PRELI regulates STAT6 and Th2
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differentiation. Based on our findings, we propose that PRELI is
involved in a mechanism in which the strength of the TCR stimulus
dictates the polarization of Th cells.
Methods
Plasmid constructs
The PRELI cDNA was amplified with polymerase chain reaction (PCR)
from human Th2 cells with PRELI-forward and PRELI-reverse primers
(Table 1) and cloned into the pFLAG-CMV-2 vector (Kodak, New Haven,
CT), creating a pFlag-PRELI construct. The pIRES2-H2Kk-PRELI con-
struct was made by amplifying PRELI with PRELI-forward and PRELI-
reverse-2 primers (Table 1), using pFlag-PRELI as a template and
subsequently ligating the PCR product to the pIRES2-H2Kk vector.18
Oligonucleotide microarrays
Pooled cord blood CD4 cells from at least 6 healthy neonates were
activated with plate-bound -CD3 (0.5 g/well) and -CD28 (0.5 g/
mL) and cultured with 2.5 ng/mL of IL-12 (Th1), 10 ng/mL of -IL-12
plus 10 ng/mL of IL-4 (Th2), or no cytokines (Th0). After 48 hours,
40 U/mL of IL-2 was added to the cultures. Samples were harvested at 0,
0.5, 1, 2, 4, 6, 12, 24, 48 and 72 hours. Total RNA was isolated using the
RNeasy Mini Kit (QIAGEN, Valencia, CA), and 100 ng of RNA was
taken for microarray sample preparation, which was performed accord-
ing to the manufacturer’s instructions (Affymetrix, Santa Clara, CA).
The samples were hybridized to Affymetrix U133 Plus 2.0 arrays
containing probes for approximately 47 000 transcripts (known genes
and expressed sequence tags). The Affymetrix signals were derived
using the robust multiarray average procedure19 in affy, a Bioconductor
software package (http://www.bioconductor.org).
Cell isolation, transfection, and culture
Hek293 cells (ATCC, Manassas, VA) were cultured in Dulbecco modified
eagle medium (DMEM; Sigma-Aldrich, St Louis, MO) supplemented with
pen/strep, 2 mM L-glutamine, 1 mM sodium pyruvate, and 10% fetal calf
serum (FCS). HeLa cells (ATCC) were cultured in modified eagle medium
(MEM) with Earle salts (both Invitrogen, Carlsbad, CA), supplemented
with pen/strep, 2 mM L-glutamine, 1 mM sodium pyruvate, 1% nonessen-
tial amino acids, and 10% FCS. For transfections, the cells were plated on
cover slips (precoated with poly-L-lysine) in 6-well plates at a density of
0.7  106 cells/2 mL of DMEM (Hek293) or 0.4  106 cells/2 mL of MEM
(HeLa) without antibiotics. After 24 hours, the cells were transfected with
1.5 g (Hek293) or 4 g (HeLa) of empty pFlag vector or pFlag-PRELI
using the Lipofectamine 2000 reagent (Invitrogen) according to the
manufacturer’s instructions.
Human mononuclear cells were isolated from cord blood from healthy
neonates or peripheral blood (buffy coats) from healthy blood donors
(Finnish Red Cross) using Ficoll-Paque isolation (Amersham Pharmacia
Biotech, Piscataway, NJ). CD4 cells were further purified using DYNAL
magnetic beads (Invitrogen). Cord blood CD4 cells from several individu-
als were pooled after the isolation. CD4 cells were activated, unless
otherwise indicated, with plate-bound -CD3 (0.5 g/well) and soluble
-CD28 (0.5 g/mL; both from Immunotech, Marseille, France)8 and
cultured at a density of approximately 2  106 cells/mL in 24-well plates in
Yssel medium (Iscove modified Dulbecco medium [IMDM; Invitrogen]
supplemented with Yssel medium concentrate, pen/strep, and 1% AB-
serum). When indicated, Th1 differentiation was induced at the time of
activation with 2.5 ng/mL of IL-12, and Th2 polarization with 10 ng/mL of
IL-4 (both from R&D Systems, Minneapolis, MN). In 7-day cultures,
40 U/mL of IL-2 (R&D Systems) was added to the cultures after 48 hours
of priming. When indicated, the cells were cultured in the presence of 0.2 to
1 mM H2O2 (Merck, Darmstadt, Germany), 1.25 mM N-acetyl-cysteine or
5 M calpastatin peptide (both from Calbiochem, San Diego, CA).
In PRELI overexpression experiments, buffy coat CD4 cells were
suspended in Optimem I (5  106 cells/100 L; Invitrogen) and transfected
with pIRES-H2Kk-PRELI or pIRES-H2Kk vectors using the nucleofection
technique (Amaxa, Cologne, Germany).18 Nucleofected cells were incu-
bated at 37°C for 16 hours (2.5  106 cells/mL), after which dead cells
were removed, and the transfected cells were enriched as previously
described.18 Briefly, dead cells, apoptotic cells, and debris were depleted
from the cultures using magnetic-activated cell-sorting (MACS) Dead Cell
Removal Microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany).
Subsequently, the remaining cells were incubated with MACSelect Kk
MicroBeads coated with H-2Kk–antibody (Miltenyi Biotec) for 15 minutes
to magnetically label the transfected cells. The magnetic separation of
H-2Kk–positive cells was done with a positive selection column placed in
the magnetic field of a MACS separator. After the enrichment, cell viability
and purity (H-2Kk–positivity) were determined by flow cytometry. The
purified H-2Kk–positive cells were activated and cultured as described
earlier in this section. In PRELI knockdown studies, naive or peripheral
blood CD4 cells, nucleofected with scrambled or PRELI-specific siRNA
oligos (1.5 g/4  106 cells/transfection; Sigma-Aldrich; Table 1), were
incubated at 37°C for 24 hours (2  106 cells/mL) and subsequently
activated and cultured in Yssel medium as described earlier in this section.
Research involving the use of human blood from unknown donors was
permitted by the Finnish Ethics Committee.
Immunofluorescent staining
To study the localization of PRELI in Hek293 or HeLa cells, the cells were
washed with the culture medium 24 hours after transfection and incubated
with 20 to 200 nM MitotrackerRed CMXRos (Molecular Probes, Eugene,
OR) for 30 minutes at 37°C. The cells were washed with cold phosphate-
buffered saline (PBS), fixed with methanol for 5 minutes at20°C, washed
twice with PBS, and blocked with goat serum (Invitrogen) for 15 minutes.
The cells were stained for Flag-PRELI with 25 g/mL mouse -Flag-M2
antibody (Sigma-Aldrich) for 1 hour. The cells were washed with PBS
(3  5 minutes), incubated with 5 g/mL goat -mouse-fluorescein isothio-
cyanate (FITC) antibody (Caltag Laboratories, Burlingame, CA) for
45 minutes, and washed with PBS. To study the effect of PRELI on the
production of reactive oxygen species (ROS) in HeLa cells, the cells were
treated in a similar manner except that, instead of being incubated with
Mitotracker, they were incubated with 20 M dihydrorhodamine 123
(DHR123; Molecular Probes) for 30 minutes at 37°C. Alexa Fluor
568-conjugated goat -mouse antibody (5 g/mL; Molecular Probes) was
used as a secondary antibody to detect overexpressed PRELI. Cells were
analyzed at room temperature with a Zeiss LSM 510 META confocal
microscope (Carl Zeiss, Jena, Germany) using Plan-Apochromat 63/1.4
oil differential interference contrast (DIC) objective. FITC and DHR123
Table 1. Sequences of primers, probes, shRNA, and siRNA
oligonucleotides used
PCR
PRELI-Fwd1 5-CGGAATTCCATGGTGAAGTATTTCCTGGGCCA-3
PRELI-Rev1 5-TGCTCTAGACTACACAAACTGTTGCTGCTGCTG-3
PRELI-Rev2 5-CGCGGATCCCTACACAAACTGTTGCTGCTGCTG-3
Taqman RT-PCR
EF1-Probe 5-(FAM)-AGCGCCGGCTATGCCCCTG-(TAMRA)-3
EF1-Fwd 5-CTGAACCATCCAGGCCAAAT-3
EF1-Rev 5-GCCGTGTGGCAATCCAAT-3
PRELI-Probe 5-(FAM)-CCGGGAAGCCTGGGTCTCCTCTAGCT-(TAMRA)-3
PRELI-Fwd 5-TGGCTGGACTGAAATCC-3
PRELI-Rev 5-CAGCTCTGGAGACACCAAAT-3
STAT6-Probe 5-(FAM)-CAGGACACCATCAAACCACTGCCAAA-(TAMRA)-3
STAT6-Fwd 5-TGGGCCGTGGCTTCAC-3
STAT6-Rev 5-CCGGAGACAGCGTTTGGT-3
siRNA/shRNA sequence
Scramble 5-GCGCGCUUUGUAGGAUUCGUU-3
PRELI-siRNA1 5-CCAAGACUAUGAAGGGUUUU-3
PRELI-siRNA2 5-CCAAGGACCUCGCCAGCAAUU-3
PRELI-shRNA 5-GGAGAAGGCAAAGGAGACGUU-3
Fwd indicates forward; Rev, reverse; FAM, 6-carboxyfluorescein; and TAMRA,
6-carboxytetramethylrhodamine.
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were excited with a 488-nm laser line and emissions were collected with a
500- to 530-nm bandpass filter. MitotrackerRed and Alexa568 were excited
with a 543-nm laser line and emissions were collected with a 560-nm
longpass filter. Images were analyzed with LSM5 software (Carl Zeiss).
To examine the effect of PRELI on m and ROS production in primary
Th cells, the nucleofected cells were harvested after 24 hours of activation
and incubated with 50 nM Mitoprobe DilC15 (Molecular Probes) in PBS or
20 M DHR123 in Yssel medium, respectively (	0.3  106 cells/500 L)
for 30 minutes at 37°C, and subsequently washed with PBS. Staining with
annexin V–FITC (BD Pharmingen, San Jose, CA) and -active caspase-
3-PE antibody (BD Pharmingen) was performed according to manufactur-
ers’ instructions. Propidium iodide (PI; Clontech, Mountain View, CA) was
mixed with the cells (5 L/0.3  106 cells in 500 L PBS) 20 seconds
before measurement. To measure the expression of chemoattractant receptor-
homologous molecule expressed on Th2 cells (CRTH2) on polarized
Th cells, 0.3 to 0.5  106 cells were first washed with PBS, then with
MACS buffer (0.5% bovine serum albumin, 2 mM ethylenediaminetetraace-
tic acid in PBS, pH 7.2) and subsequently incubated with 5 L of
CRTH2-phosphatidylethanolamine (PE) antibody for 10 minutes at 4°C.
Next, the cells were washed twice with MACS buffer and resuspended
in 1% formalin/PBS. Samples were measured with a FACSCalibur
fluorescence-activated cell sorter and analyzed with CellQuest Pro (both
from BD Biosciences, San Jose, CA).
Intracellular cytokine staining
Cytokine staining and analysis was performed as previously described.18
The antibodies used were -IFN
-FITC (3 L/100L permeabilization
buffer) and -IL4-PE (3 L; both from Caltag Laboratories) or -IL4-PE
(1 L; BD Pharmingen).
Taqman reverse transcription–polymerase chain reaction
Samples were prepared for Taqman reverse transcription–polymerase chain
reaction (RT-PCR) analysis as described previously.20 Gene expression
levels were measured using the TaqMan ABI Prism 7700 Sequence
Detection System (Applied Biosystems, Foster City, CA).21 The housekeep-
ing gene elongation factor 1 (EF1) was used as a reference transcript.
The primers and probes used (MedProbe, Oslo, Norway; Table 1) were
designed using Primer Express software (Applied Biosystems).
Western blotting
The cell lysates were sonicated, and equal amounts of protein were run on
10% sodium dodecyl sulfate–polyacrylamide gels and transferred to a
nitrocellulose membrane (Hybond enhanced chemiluminescence [ECL];
GE Healthcare, Piscataway, NJ). Proteins were detected using the following
antibody dilutions: 1:1000 sheep -PRELI-antiserum (kind gift from Dr
Elisabeth Fox, Leeds, United Kingdom), 1:500 mouse -STAT6 (BD
Biosciences), 1:1000 rabbit -phospho-STAT6 (Tyr641; Cell Signaling
Technology, Beverly, MA), 1:200 rabbit -STAT1 p84/p91 (E-23; Santa
Cruz Biotechnology, Santa Cruz, CA), 1:200 rabbit -STAT4 (C-20; Santa
Cruz Biotechnology), 1:500 rabbit -calpain 1 large subunit (-type; Cell
Signaling Technology) or 1:20 000 mouse --actin (Sigma-Aldrich).
Horseradish peroxidase–conjugated secondary antibodies were: 1:10 000
goat -mouse IgG (Santa Cruz Biotechnology), 1:10 000 goat -rabbit Ig
(BD Biosciences) or 1:20 000 donkey -sheep (Jackson ImmunoResearch
Laboratories, West Grove, PA). The protein bands were visualized with
ECL (GE Healthcare).
Results
PRELI is up-regulated in response to T-cell activation in human
primary T helper cells
We identified PRELI as an activation-induced gene in primary
human Th cells using Affymetrix oligonucleotide arrays. This
study was conducted to identify novel genes involved in the
regulation of early human primary Th-cell differentiation and
activation (unpublished results). The expression of PRELI mRNA
was highly increased when naive CD4 cells (Thp) were subjected
to TCR activation. However, it was not differentially regulated by
the Th1/Th2 polarizing cytokines IL-12 or IL-4. PRELI expression
increased for the first 24 hours after activation and decreased
thereafter (Figure 1A). A similar induction profile was also
obtained at the protein level (Figure 1B and data not shown).
PRELI is localized in mitochondria and reduces the
mitochondrial membrane potential (m)
To clarify the cellular function of PRELI, we first studied its
localization. PRELI contains an MSF1 domain whose function is
unknown but may have a role in intramitochondrial protein sorting.
MitotrackerRed CMXRos costaining was used to determine whether
PRELI localizes to mitochondria. Exogenously expressed PRELI
was localized in the mitochondria of HeLa, Hek293, and primary
CD4 cells (Figure 2A and data not shown). This is consistent with
the description of mitochondrial localization of PRELI in HeLa
cells and a mitochondrial targeting sequence in the N-terminal
domain of the PRELI protein.16 Interestingly, the fluorescence
intensity of the membrane potential sensitive Mitotracker was
lower in HeLa cells overexpressing pFlag-PRELI than in cells not
overexpressing PRELI, indicating that the m was reduced by
PRELI (Figure 2A). To study this in human primary CD4 cells,
we used 2 approaches: PRELI overexpression and knockdown by
specific siRNAs. Consistent results were obtained with both of
these approaches using flow cytometric analysis. Overexpression
of PRELI increased the proportion of cells with reduced m,
whereas silencing PRELI significantly decreased the number of
these cells, confirming that PRELI reduces the m in human
primary Th cells (Figure 2A). To verify the overexpression and
knockdown of PRELI in our experiments, we analyzed the levels of
PRELI protein by Western blotting before and 24 hours after the
activation. In the overexpression experiments, the transfected cells
were enriched before the culture. Figure 2C shows the representa-
tive levels of PRELI protein in the overexpression and knockdown
Figure 1. PRELI is up-regulated in response to activation in human primary
T helper cells at the mRNA and protein level. (A) Expression of PRELI mRNA.
Naive CD4 cells were activated and cultured in the absence (Th0) or presence of
IL-12 (Th1) or IL-4 (Th2). The figure represents the fold change of PRELI expression
in Th0, Th1, and Th2 cells versus nonactivated (Thp) cells (Affymetrix probe set
(224232_s_at). Representative data from 3 independent experiments. (B) Expres-
sion of PRELI at protein level. Naive CD4 cells were cultured as in panel A for 6 and
24 hours. Samples from 5 donors (neonates) were pooled.
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experiments. In this study, we often observed that the effect of
PRELI overexpression had a larger effect than knockdown (eg,
Figure 2A,B). This may be due to the fact that, in the overexpres-
sion method, the transfected cells are purified prior to the activation
and polarization, unlike in the siRNA approach. In addition, PRELI
is already overexpressed at the time of the activation, whereas the
effects of knockdown start to appear after the activation, that is,
when the endogenous PRELI is induced (Figure 2C). This can also
partly account for the larger effects of PRELI overexpression than
of the siRNA approach.
PRELI induces production of ROS by mitochondria and
apoptotic cell death in human primary T helper cells
Various death or stress signals induce the loss of m, resulting
in mitochondrial membrane permeabilization, generation of
ROS and the subsequent release of cytochrome c and caspase-3
activation, thereby leading to the activation of apoptotic cell
death. Mitochondria are the major source of ROS but they can
also serve as their targets during the apoptotic process.22 Our
finding that PRELI altered the m suggested that overexpres-
sion of PRELI could influence ROS production by mitochon-
dria. To study this, HeLa cells were transfected with pFlag-
PRELI and the ROS produced by the mitochondria were stained
with DHR123. The production of ROS was slightly induced in
the cells where PRELI was overexpressed (Figure 2B). To
confirm these results, CD4 cells overexpressing PRELI or the
control plasmid were activated, stained with DHR123, and
analyzed by flow cytometry. PRELI overexpression slightly
increased the ROS production also in primary Th cells (Figure
2B). This was further confirmed in experiments where PRELI
was specifically knocked down using siRNA oligos (siRNA1 or
2) or a PRELI-specific short hairpin RNA (shRNA) plasmid
(Figure 2B and data not shown).
These findings led us to investigate whether PRELI plays a role
in primary Th cell apoptosis. Furthermore, because IL-4 is known
to protect cells from apoptosis by regulating proteins mediating the
Figure 2. PRELI localizes in mitochondria, alters the
m, and induces mitochondrial ROS production.
(A) PRELI localizes in mitochondria and reduces m.
HeLa cells were stained for pFlag-PRELI (transfected
cell indicated by white arrow). Mitochondria were visual-
ized with MitotrackerRed CMXRos. Intensity profiles
(middle panel) visualize FITC (PRELI overexpression)
and Mitotracker fluorescence intensities in these cells.
CD4 cells (right panel) were nucleofected with pIRES-
H2Kk (control) or PRELI overexpression vector (black
bars) and subsequently sorted. Cells were also nucleo-
fected with scramble or PRELI-siRNAs ( ). Subse-
quently, the cells were activated (with -CD3 0.1 or
0.5 g/well and -CD28) for 24 hours, stained with
Mitoprobe DilC15 and analyzed by flow cytometry. Two
separate cell populations with high and low Mitoprobe
DilC15 intensities seen in the flow cytometric analysis
depict cells with active and reduced membrane poten-
tials, respectively (histograms not shown). Thus, the
percentage of cells with reduced membrane potential
stands for the proportion of cells with low Mitoprobe
DilC15 intensity in a sample. Bars represent the mean
values plus or minus SEM of 7 independent experiments.
(B) PRELI induces mitochondrial ROS production. Over-
expressed pFlag-PRELI (Alexa 568, red) and mitochon-
drial ROS production stained with DHR123 (green).
CD4 cells (right panel), nucleofected and activated as in
panel A, were stained with DHR123 and analyzed by flow
cytometry. Bars represent the average fold changes plus
or minus SEM of ROS intensity in PRELI overexpression
or PRELI-siRNA samples compared with the correspond-
ing control sample (pIRES-H2Kk or scramble). The val-
ues of the control samples were set as 1. Overexpression
and siRNA data are obtained from 7 and 4 independent
experiments, respectively. (A,B) m and ROS were
measured from living cell populations according to for-
ward scatter/side scatter (FSC/SSC) plots (overexpres-
sion experiments) or total cell population (siRNA experi-
ments). Statistical significances were calculated using
the 2-tailed paired t test. (C) Representative levels of
PRELI protein in overexpression and knockdown ex-
periments. In overexpression experiments the periph-
eral blood CD4 cells, transfected with pIRES-H2Kk-
PRELI or pIRES-H2Kk control vector, were enriched
16 hours after the nucleofection and subsequently
activated for 24 hours. In PRELI knockdown experi-
ments, the cells nucleofected with scrambled- or PRELI-
siRNA oligos were incubated for approximately
24 hours and subsequently activated for 24 hours.
Samples were harvested for Western blotting before
(in overexpression experiments after the enrichment)
and after the activation. Vertical lines have been
inserted to indicate a repositioned gel lane. OE indi-
cates overexpression.
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mitochondrial apoptosis pathway8,9 and by maintaining the mito-
chondrial membrane potential,10 we also investigated the combined
effects of IL-4 and PRELI on m and apoptosis. Human primary
CD4 cells nucleofected with the PRELI overexpression vector or
PRELI-siRNA oligos (and their corresponding controls) were
activated and cultured with or without IL-4 for 24 hours. The cells
were stained with PI to determine cell viability (PI-negative cells)
by flow cytometry. Early apoptosis was studied by detecting
annexin V intensities in PI-negative cell populations. In parallel,
the cells were also stained with active–caspase-3 antibody and
Mitoprobe (m). The annexin V intensity, as well as the number
of cells with active caspase-3 and reduced m, was higher in the
samples overexpressing PRELI than in the control cells (Figure
3A), indicating that PRELI induces the mitochondrial apoptosis
pathway in human Th cells. In addition, PRELI reduced cell
viability. IL-4 partly inhibited the effects of PRELI, indicating that
while PRELI and IL-4 have opposing effects on the mitochondrial
apoptosis pathway, IL-4 cannot completely reverse the effect of
PRELI. Consistent results were obtained in PRELI knockdown
experiments (Figure 3B). The removal of PRELI significantly
decreased annexin V intensity as well as the number of cells with
reduced m. Furthermore, the number of cells with active
caspase-3 was slightly decreased. The presence of IL-4 further
down-regulated these parameters, indicating that removal of PRELI
and IL-4 have additive effects on the mitochondrial apoptosis
pathway. Consistent with this, the cell viability was improved by
PRELI-siRNAs and further up-regulated by IL-4. IL-4 treatment
alone significantly increased cell viability and down-regulated the
other parameters, as expected. The fact that the effect of PRELI on
caspase-3 in the knockdown experiments was rather small may
indicate that its influence is, at least partially, due to a caspase-
independent apoptosis pathway, that has been previously described
in human primary T lymphocytes. This pathway is characterized by
ROS production, loss of m, and phosphatidylserine expo-
sure.23,24 Taken together, these results suggest that while PRELI
and IL-4 counter-regulate the mitochondrial apoptosis pathway in
human primary Th cells, the addition of IL-4 only partly reverses
the effect of PRELI.
PRELI down-regulates Th2 cell differentiation
After establishing that PRELI and IL-4 counterregulate the mito-
chondrial apoptosis pathway in primary Th cells, we wanted to
investigate the role of PRELI on Th-cell differentiation. For this,
CD4 cells nucleofected with a control or PRELI overexpression
vector were polarized into Th1 and Th2 cells for 7 days. Subse-
quently, we measured the production of IFN
 and IL-4, the
hallmark cytokines produced by Th1 and Th2 cells, respectively.
Our results show that PRELI influences the differentiation of Th2
cells. The number of IL-4-producing Th2 cells was significantly
reduced when PRELI was overexpressed in the cells (Figure 4A).
Consistent data were obtained in PRELI knockdown experiments.
Figure 3. PRELI induces the mitochondrial apoptosis pathway in Th cells and is partly inhibited by IL-4. (A) Overexpression of PRELI induces mitochondria-mediated
apoptosis and this is partly counteracted by IL-4. CD4 cells nucleofected with pIRES-H2Kk or PRELI overexpression vector were sorted and activated as in Figure 2A, cultured
with or without IL-4 for 24 hours, and stained and analyzed by flow cytometry. (B) Knockdown of PRELI and IL-4 treatment has additive effects on the mitochondrial apoptosis
pathway. CD4 cells nucleofected with scramble or PRELI-siRNAs were cultured, stained, and analyzed as in panel A. (A,B) Cell viability  PI-negative cells. Bars represent
the mean values plus or minus SEM of 4 to 5 independent experiments, except that caspase-3 was measured in 2 independent overexpression experiments that included IL-4
treatment. In addition, caspase-3 was measured in 5 independent PRELI overexpression experiments without the IL-4 treatment (data not shown). In these experiments PRELI
significantly increased the proportion of cells with active caspase-3 (*P  .05). In graphs of annexin V, bars represent the average fold changes plus or minus SEM of
annexin V intensity between the untreated control sample and the other samples. The values of the untreated control samples were set as 1. m was measured from living cell
populations according to FSC/SSC plots (overexpression experiments) or total cell population (siRNA experiments). The percentage of cells with reduced m was determined
as described in Figure 2A. Statistical significances were calculated using the 2-tailed paired t test. OE indicates overexpression.
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Since the number of IL-4–producing cells after the first round of
human Th2 cell polarization is typically less than 10%, as
previously reported,25 we analyzed the effect of PRELI on the
expression of another Th2 cell marker; the cell surface molecule
CRTH2. CRTH2 is preferentially expressed on Th2 cells and its
expression correlates strongly with the production of IL-4 and
IL-13 in human Th2-skewed cultures.26,27 As expected, depletion of
PRELI increased the number of CRTH2-positive Th2 cells com-
pared with the control cells (Figure 4B). No reproducible effect on
IFN
 production by Th1 cells could be detected in experiments
involving PRELI overexpression (n  3, P  .28) or knockdown
(n  9, P  .42; data not shown).
STAT6 is down-regulated by PRELI and oxidative stress in
human primary T helper cells
To dissect the mechanism behind PRELI’s effect on Th2 differentia-
tion, we looked for any possible effect on STAT6, the key
transcription factor involved in driving Th2 differentiation. Our
results show that PRELI down-regulates the amount of STAT6 at
the protein level. Removal of PRELI from cord blood or peripheral
blood CD4 cells led to up-regulation of STAT6 protein levels,
whereas STAT6 mRNA levels were not notably affected (Figure
5A). This indicates that PRELI regulates STAT6 at the posttranscrip-
tional level. We also investigated the effect of PRELI on the
Th1-specific transcription factors STAT1 and STAT4. The deple-
tion of PRELI had no reproducible effect on STAT1 or STAT4
proteins in 7 (P  .97) or 6 (P  .35) independent experiments,
respectively (Figure 5A and data not shown).
In addition, we investigated whether the IL-4 induced tyrosine
(Y641) phosphorylation of STAT6 was affected in response to
PRELI in CD4 cells. Peripheral blood CD4 cells overexpressing
PRELI or the empty control vector were activated and cultured in
the presence of IL-4 for 30 minutes, 1 hour or 24 hours.
Subsequently, the levels of total STAT6 and phosphorylated STAT6
were determined by Western blotting. The amount of phosphory-
lated STAT6 was also reduced to the same extent as that of the total
protein (Figure 5B). This indicates that PRELI down-regulates
levels of the STAT6 protein with no additional effect on its
IL-4–dependent phosphorylation.
To clarify the mechanism by which PRELI down-regulates
STAT6, we examined whether STAT6 was regulated by the cellular
redox state. Exposure of cells to H2O2 is often used as a model of
oxidative stress. We observed that the amount of STAT6 protein
decreased in a dose-dependent manner in response to increasing
cellular ROS concentration, whereas the expression of STAT6
mRNA was not similarly affected (Figure 5C). This indicates that
STAT6 is down-regulated in human primary Th cells by oxidative
stress at the posttranscriptional level. Levels of STAT1 and STAT4
were not similarly affected by H2O2 as the level of STAT6 was
(Figure 5C and data not shown), excluding the possibility of
nonspecific, general protein degradation induced by the H2O2
treatment.
Consistent results were obtained when cellular ROS were
neutralized by an antioxidant N-acetyl-cysteine (NAC). The amount
of STAT6 was higher in the cells treated with NAC compared with
the nontreated cells, confirming that ROS down-regulate STAT6
Figure 4. PRELI down-regulates Th2 cell polarization.
(A) Overexpression of PRELI down-regulates the num-
ber of IL-4 producing Th2 cells. CD4 cells nucleofected
with a control (pIRES-H2Kk) or PRELI overexpression
vector were polarized into Th2 cells for 7days. Subse-
quently, the cells were stimulated with phorbol myristate
acetate  ionomycin to induce the cytokine production or
not stimulated (negative controls). Subsequently, the
production of IL-4 and IFN
was determined by intracellu-
lar cytokine staining and flow cytometric analysis.
(B) Knockdown of PRELI induces the expression of a
Th2 cell surface marker CRTH2. CD4 cells nucleo-
fected with scramble or PRELI-siRNAs were cultured
under Th1 and Th2 polarizing conditions for 6 to 7 days.
After this, CRTH2 expression was analyzed by flow
cytometry. Th1 cells were used as negative controls.
(A,B) Bars represent the mean values plus or minus
SEM, calculated from independent experiments (overex-
pression, n  3; siRNA, n  8). Statistical significances
were determined using the 2-tailed paired t test. Dot plot
figures show representative data from the experiments.
OE indicates overexpression.
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protein levels (Figure 5D). Down-regulation of ROS by NAC was
verified by DHR123-staining and flow cytometric analysis (data
not shown). Again, STAT1 or STAT4 were not affected in the same
way as STAT6 (Figure 5D and data not shown).
Calpain, an oxidative stress–induced cysteine protease that
down-regulates STAT6, is regulated by PRELI
STAT6 has been reported to be negatively regulated by the cysteine
protease calpain in mouse T-cell lines and mast cells.12,13 Calpain,
in turn, is activated by oxidative stress.28,29 Therefore, we wanted to
investigate whether calpain was a mediator of PRELI-induced
down-regulation of STAT6 in human primary Th cells.
Oxidative stress (H2O2) induces the cleavage/activation of
inactive procalpain (80 kDa) to active calpain (75 kDa) in cord
blood CD4 cells (Figure 5E). In addition, as reported in other cell
types, we observed that STAT6 is down-regulated by calpain in
human primary Th cells. Calpastatin, an endogenous calpain inhib-
itor, prevents the autoproteolytic cleavage of the inactive procal-
pain to an active form, leading to the accumulation of inactive
procalpain in the cell.30 In response to calpastatin treatment, the
amount of inactive calpain in the cells was increased, indicating
that this inhibitor reduced calpain activation. In addition, levels of
STAT6 were also increased in response to calpain inhibition,
supporting the conclusion that STAT6 is down-regulated by calpain
in primary Th cells (Figure 5F). Furthermore, overexpression of
PRELI in Hek293 cells clearly induced the cleavage/activation of
calpain (Figure 5G). Taken together, these results suggest that
down-regulation of STAT6 by PRELI could be mediated by
oxidative stress and calpain activation.
The strength of the TCR stimulus influences the expression of
PRELI and Th2 differentiation
It is well established that the strength of the TCR signal influences
Th1/Th2 polarization. A strong TCR stimulus promotes Th1
differentiation, while weaker TCR stimuli favor Th2 polariza-
tion.4,5 Interestingly, the intracellular levels of PRELI also corre-
lated with the strength of the TCR activation. CD4 cells were
activated with different concentrations of -CD3 (125, 250, or
500 ng/well) and -CD28 for 24 hours and subsequently harvested
for Western blotting and Taqman RT-PCR analysis. The extent of
PRELI induced, at both the protein and mRNA levels, was clearly
proportional to the concentration of -CD3 used for stimulation
(Figure 6A). In addition, CD4 cells nucleofected with scrambled-
or PRELI-siRNA oligos were activated as described earlier in this
section and cultured under Th1- or Th2-polarizing conditions for
quantified with an MCID and the active versus inactive calpain ratios were calculated
in each sample. Subsequently, the active/inactive calpain ratio of the control
(untreated) sample was set as 1 and the fold changes of the ratios of the other
samples were calculated in relation to the control sample. Bars represent the mean
values plus or minus SEM of the fold changes of different replicates. Representative
data from 2 experiments are shown. (F) STAT6 is up-regulated in response to calpain
inhibition. CD4 cells were activated and cultured for 24 hours with or without
calpastatin peptide (5 M) and subsequently harvested for Western blotting. STAT6
protein bands were quantified with an MCID and normalized against -actin. Vertical
lines have been inserted to indicate a repositioned gel lane. The relative ratios of
active versus inactive calpain were determined as described in panel E. Representa-
tive data from 5 independent experiments are shown. (G) Overexpression of PRELI
in Hek293 cells induces activation of calpain. Hek293 cells transfected with a control
vector (empty pFlag) or pFlag-PRELI were harvested for Western blotting 24 hours
after transfection. The relative ratios of active versus inactive calpain were deter-
mined as described in panel E. Data are representative of 2 independent experi-
ments. (A,B,D,F) Statistical significances were determined using the 2-tailed paired
t test. OE indicates overexpression.
Figure 5. PRELI and oxidative stress down-regulate STAT6 and activate
calpain, a known STAT6 protease. (A) Knockdown of PRELI leads to increase of
STAT6 at the protein level. Nucleofected CD4 cells were activated for 24 hours and
subsequently harvested for Taqman RT-PCR analysis and Western blotting. Protein
bands were quantified with a microcomputer imaging device (MCID) and normalized
against -actin. Bars represent the average fold changes plus or minus SEM,
calculated from independent experiments (STAT6 protein, n  10; STAT6 mRNA,
n  4). (B) PRELI does not influence the tyrosine (Y641) phosphorylation of STAT6.
CD4 cells nucleofected with pIRES-H2Kk or the PRELI overexpression vector were
activated and cultured in the presence of IL-4 for 1 hour and subsequently harvested
for Western blotting. Protein bands were quantified and normalized, as in panel A.
Representative data from 5 independent experiments are shown. (C) STAT6 is
down-regulated at the protein level by oxidative stress in human primary Th cells.
Cord blood CD4 cells were activated for 20 hours and subsequently exposed to
increasing concentrations of H2O2 for 4 hours. The protein and mRNA levels of
STAT6 were analyzed by Western blotting and Taqman RT-PCR analysis. A portion of
the cells was stained with DHR123, to assess ROS production, and analyzed by flow
cytometry. Representative data from 4 independent experiments are shown.
(D) Neutralization of intracellular ROS increases the level of STAT6. CD4 cells were
activated and cultured with or without 1.25 mM NAC for 24 hours, after which the cells
were harvested for Western blotting. STAT6 protein bands were quantified and
normalized as in panel A. Representative data from 6 independent experiments are
shown. (E) Oxidative stress induces calpain activation in human Th cells. Exposure of the
cells to H2O2 was performed as in panel C (black arrow, inactive procalpain [80 kDa];
gray arrow, active calpain [75 kDa]). The active and inactive calpain bands were
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7 days. The expression of CRTH2, a Th2 cell marker, was then
analyzed by flow cytometry. Our results show that Th2 differentia-
tion was inhibited when primary Th cells were activated with a
strong TCR stimulus, whereas Th2 differentiation was enhanced
when PRELI was knocked down (Figure 6B). These results
indicate that the strength of the TCR activation, as well as the
amount of PRELI in cells, influences the ability of a naive CD4
cell to differentiate into Th2 cell (Figures 4 and 6B). Importantly,
our results suggest that PRELI is a mediator, at least in part, in
determining the effects of the strength of TCR stimulus on Th2
differentiation.
The relative proportion of Th1 versus Th2 cells generated plays a
critical role in determining the outcome of the host immune response to
an infection. Identification of the various factors involved in regulating
this balance remains an active area of investigation. It was therefore of
interest to examine the consequence of PRELI depletion under condi-
tions where differentiation of both Th1 and Th2 was simultaneously
promoted. For this, we cultured CD4 T cells nucleofected and acti-
vated as described earlier in this section in the presence of both IL-12
and IL-4 for 7 days and subsequently measured the CRTH2 expression
and IFN
 production by these cells. As shown in Figure 6C (scramble),
Th2 cell generation was very low at all concentrations of -CD3. We
interpret these findings to indicate that the effects of IL-12 override those
of IL-4, at least at the level of Th differentiation. Interestingly, however,
knockdown of PRELI resulted in a significant increase in Th2 cell
generation compared with the scramble control. In contrast, PRELI
silencing had no detectable effect on IFN
-producing cell populations
(Figure 6C). On one level, these results provide additional support for
the specific effects of PRELI in regulating Th2 cell differentiation. In
addition, however, they also suggest a role for this effect in defining the
relative proportion of Th1 versus Th2 cells that can be obtained from
naive precursor cells.
Discussion
In this study, we have identified PRELI as a novel, activation-
induced regulator of T helper cell apoptosis and differentiation.
Our results suggest that these new functions for PRELI are
mediated by an overlapping mechanism, by the regulation of the
cellular redox state.
The mechanism by which PRELI affects the m and ROS
production is presently unknown. In Saccahromyces cerevisiae,
Ups1p, the homologue of human PRELI (31% identity), regulates
mitochondrial shape and the processing of the GTPase Mgm1p via
an unknown mechanism.31 Because human PRELI was able to
replace Ups1p in Mgm1p processing in yeast cells, it was
considered to be likely that in human cells PRELI acts on optic
atrophy 1 (OPA1), the human homologue of Mgm1p. OPA1 is an
important regulator of mitochondrial membrane dynamics and
apoptosis in human cells.32,33 Different isoforms and cleavage
products of OPA1 have different effects on mitochondrial function
and apoptosis, and their abundance varies greatly between organs.
The differential processing of these isoforms plays an important
role in the regulation of mitochondrial function and susceptibility
to apoptosis. Interestingly, the variant that induces cytochrome c
and caspase-mediated apoptosis is found predominantly in liver,
kidney, and thymus.34 This resembles the expression of PRELI,
which has also been suggested to be important for the development
of vital and immunocompetent organs.15
Our preliminary results (unpublished data) suggest that PRELI
does not affect the expression levels of OPA1 isoforms in human
CD4 cells. However, whether PRELI influences the function of
OPA1, remains to be determined. It also needs to be emphasized
that distinctions in OPA1 processing exist between yeast and
humans.35 Therefore, the mechanisms involved in yeast do not
necessarily apply to humans. Furthermore, the yeast homologue of
PRELI, Ups1p, was suggested to have additional targets in
mitochondria,31 suggesting that PRELI may also engage substrates
other than OPA1.
Given that IL-4 partially neutralized the proapoptotic effects of
PRELI, we expected that PRELI could possibly have greater
impact on Th1 than Th2 differentiation. However, we found that
PRELI negatively influences Th2 cell polarization, with no repro-
ducible effect on IFN
 production by Th1 cells. Consistent with
these findings, PRELI was found to down-regulate STAT6, the key
Figure 6. A strong TCR stimulus induces the expres-
sion of PRELI, and they both inhibit Th2 cell develop-
ment. (A) PRELI is induced at the mRNA and protein
levels by increasing strength of the TCR stimulus. Naive
CD4 cells were activated with different concentrations
of -CD3 (125, 250, or 500 ng/well) and -CD28 for
24 hours and subsequently harvested for Western blot-
ting and Taqman RT-PCR analysis. Representative data
from 4 independent experiments are shown. (B) The
strength of the TCR stimulus and the amount of PRELI in
cells influence Th2 differentiation. CD4 cells nucleo-
fected with scrambled- or PRELI-siRNA oligos (1 or 2)
were activated as in panel A and cultured under Th1- or
Th2-polarizing conditions for 7 days. The cells were
stained with CRTH2-PE and analyzed by flow cytometry.
Th1 cells were used as negative controls. Representa-
tive data from 2 independent experiments are shown.
White bars represent the mean value plus or minus SEM,
calculated from PRELI-siRNA1 and PRELI-siRNA2 cul-
tures from the representative experiments. (C) PRELI
influences the relative proportion of Th cells under condi-
tions that enable both Th1 and Th2 polarization. CD4
cells nucleofected and activated (as described earlier in
this paragraph) were cultured in the presence of both
IL-12 (2.5 ng/mL) and IL-4 (10 ng/mL). After 7 days of
culture, expression of CRTH2 was analyzed (as de-
scribed earlier in this paragraph). Production of IFN
was
measured by intracellular cytokine staining. Representa-
tive data from 2 biologic replicates with PRELI-siRNA2
are shown.
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molecule driving IL-4–induced Th2 differentiation. The effect of
PRELI on STAT6 was restricted to the protein level. Importantly,
our findings suggest that this function of PRELI was mediated
through ROS-dependent activation of calpain. Taken together, our
results suggest that PRELI, by influencing the intracellular redox
state, influences Th2-cell development on 2 levels. It induces the
mitochondrial apoptosis pathway in these cells, thus counteracting
the protective effect of IL-4. In addition, it down-regulates STAT6
and Th2 differentiation.
It is known that Th1/Th2 cell differentiation is influenced by the
strength of the activation stimulus. A strong TCR stimulus and
enhanced calcium signaling increase the activity of calpains in
T lymphocytes.36,37 These processes have all been shown to favor
Th1 over Th2 differentiation.4,38,39 It has previously been suggested
that strong TCR signals may influence T cell differentiation by
promoting strong calcium signaling, calpain activation, and a
subsequent degradation of STAT6.12,13,39 We showed that PRELI is
highly up-regulated in response to T cell activation and that its
expression correlates with the strength of the TCR stimulus. In
addition, both a strong TCR stimulus and PRELI were shown to
inhibit Th2 differentiation. Our data suggest that PRELI is involved
in the mechanism through which the strength of the TCR stimulus
influences the polarization of Th cells. Thus, it is possible that, in
vivo, a strong TCR stimulus, besides enhancing calcium signaling
and subsequent calpain activation, strongly induces the expression
of PRELI, leading to increased degradation of STAT6 and de-
creased Th2 development. Similarly, a weaker activation would
induce less PRELI and allow more potent Th2 differentiation.
Importantly, our results also suggest a role for PRELI in influenc-
ing the relative proportions of Th cell types under conditions that
enable both Th1 and Th2 polarization. Overall, this study identifies
PRELI as a novel factor influencing human primary Th cell death
and Th2 differentiation, thus providing new insights into the
signaling mechanisms that control the selective activation of
human Th cell subsets.
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